Science
/AAAS
Skip to content
AAAS.ORG
Feedback
Help
Librarians
Alerts
Access Rights
Sign In
Science Magazine
Daily News
Science Signaling
Science Translational Medicine
SAGE KE
Science Careers
All HighWire Journals
Advanced
News
Science Journals
Careers
Communities
Multimedia
Topics
Subscribe
Help
Meetings & Events
About
Science
Careers
Contact
My Science Career
My Account
My Résumés
My Cover Letters
My Applications
My Jobs
My Searches
My Job Alerts
Find a Job
Job Search
Browse All Jobs
By Employer
Biotechnology Jobs
Faculty Jobs
Postdoctoral Jobs
For Employers
Search Résumés
Post a Job
Meetings & Events
Contact
Career Magazine
Issues & Perspectives
Career Advice
The Job Market
Career Profiles
Life & Career
Diversity Issues
CTSciNet
Blogs
Grants & Funding
Funding Home
GrantsNet Account
Search GrantsNet
Funding Directory
Funding News
Post a Grant
Tools & Tips
How-To Series
Outreach
Graduate Programs
Multimedia
Facebook
Community
MySciNet
CTSciNet
Forum
Science
Home
>
Science
Careers
>
Funding
>
Search GrantsNet
>
Search Results
>
Programs
Grants & Funding
GrantsNet Tools:
Saved Searches
|
Saved Grants
|
GrantsNet Express Alerts
National Institutes of Health/National Institute of Allergy and Infectious Diseases
Published Date: June 29, 2010
Program Information
Program Name:
Martin Delaney Collaboratory: Towards an HIV-1 Cure (U19)
Program URL:
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-10-009.html
Type of Scientists Funded:
Senior Scientist/Faculty
Program Description:
The National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Mental Health (NIMH), National Institutes of Health, encourage grant applications from institutions/organizations to address the problem of HIV-1 persistence in HIV-1-infected persons treated with suppressive antiretroviral drug regimens.
This funding opportunity announcement (FOA) will support research in four areas: (1) basic research to identify and characterize the cellular reservoirs of HIV-1 in treated individuals; (2) development of assays that are physiologically relevant and that comprise a spectrum of cell types that may harbor latent HIV-1 or permit viral replication in the presence of effective antiretroviral drug regimens; (3) screening of drug candidates that target latent/persistent HIV-1; and (4) development and initial testing of new agents or strategies aimed at the eradication of HIV-1.
The goal of this initiative is to expand the knowledge base on HIV-1 latency and persistence so that eradication strategies can be designed, developed, and evaluated. The application must include basic research and translational activities as essential components, and collaborators must include a private sector entity. This FOA will utilize the U19 award mechanism.
For this funding opportunity, the total amount of funds available from NIAID and NIMH is $8.5 million for fiscal year 2011. NIAID and NIMH expect to fund one or two awards.
Public Contact Information
Name:
Tamara Kees
Title:
Organization:
National Institutes of Health/National Institute of Allergy and Infectious Diseases
Department:
Division of Extramural Activities
Address:
Room 2227
MSC-7614
6700B Rockledge Drive
Bethesda, Maryland 20892-7614
Phone:
301-496-7065
Fax:
301-493-0597
E-mail:
TKees@niaid.nih.gov
Country:
United States
Program Award Term and Application Process
Award Term Fixed or Variable?
Variable
Minimum Term
Maximum Term
Award Renewable?
No
Does an individual or institution apply to the program?
Institution
Is there a training component to this grant?
Is there an application deadline?
Yes
Application deadline(s):
10/04/2010,
11/04/2010
Deadline Comments
Letters of Intent Receipt Date: October 4, 2010 Application Receipt Dates: November 4, 2010
Program FUNDS
Stipend Information:
Annual stipend type:
Not Applicable
Research Allowance Information:
Annual research allowance type:
Not Applicable
Indirect Costs (Institutional Funds) Information:
Indirect costs type:
Not Applicable
Other Costs Information:
Other Costs type:
Not Applicable
Program Eligibility Requirements
Research Areas:
Biology, Cell Biology, Chemistry, Disease-Specific Research: HIV/AIDS, Immunology, Social, Behavioral and Economic Sciences, Other (specify): Antiretroviral Drug
Application by invitation or nomination only?
No
Are awards limited to specific groups?
None provided
Must applicants be U.S. citizens and/or permanent residents?
U.S. geographic limits?
No
International geographic limits?
Institutional limits?
Yes
Details
The following organizations/institutions are eligible to apply: * Public/State Controlled Institutions of Higher Education * Private Institutions of Higher Education * Hispanic-serving Institutions * Historically Black Colleges and Universities (HBCUs) * Tribally Controlled Colleges and Universities (TCCUs) * Alaska Native and Native Hawaiian Serving Institutions * Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education) * Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education) * Small Businesses * For-Profit Organizations (Other than Small Businesses) * State Governments * Indian/Native American Tribal Governments (Federally Recognized) * Indian/Native American Tribally Designated Organizations * County Governments * City or Township Governments * Special District Governments * Independent School Districts * Public Housing Authorities/Indian Housing Authorities * U.S. Territory or Possession * Indian/Native American Tribal Governments (Other than Federally Recognized) * Regional Organizations * Other(s): o Eligible Agencies of the Federal Government o Faith-based or Community-based Organizations.
Non-domestic (non-U.S.) entities (Foreign Organizations) are not eligible to serve as primary applicants for this FOA. However, foreign components may submit a research project or core within a domestic application, under this FOA. The instructions for submission of research projects or cores are located in the supplemental instructions (Section IV.6, Other Submission Requirements).
Non-research activity allowed for postdoctoral and junior faculty awards?
If yes, specify at least one of the following: percentage time and activities allowed
Other eligibility requirements:
Multiple PDs/PIs may be designated on the primary U19 application. However, only one Project Leader (PL) or Core Leader (CL) may be designated for each project or core, respectively, for multi-project U19 applications.
A PD/PI, or PD/PI on a multi-PI application, or U19 PL may serve as a collaborator for another application provided there is no scientific overlap with the application submitted by the PD/PI, multi-PD/PI, or U19 PL. However, an investigator may only be a PD/PI, multi-PD/PI, or U19 PL on one application.
The PD/PI must devote at least 2.4 person months effort to the project (this includes a minimum 0.6 person months effort to the management and operations activities).
Applicants may submit more than one application, provided they are scientifically distinct. Resubmission applications are not permitted in response to this FOA. Renewal applications are not permitted in response to this FOA.
Program competition information
Number of Applicants in Most Recent Competition Year:
Number of Awards in Most Recent Competition Year:
Institutional Award Rates
Category
# Applicants
# Awards
Institutional Awards
Awardee's subsequent careers/accomplishments tracked after end of term?
Total dollars awarded in the most recent competition year